Innoviva (INVA) Tax Rate (2014 - 2026)

Innoviva (INVA) reported Tax Rate of 20.46% for Q1 2026, up 4119.0% on a YoY basis from 0.49% in Q1 2025, and up 153.38% quarter-over-quarter from 8.08% in Q3 2025.

Innoviva (INVA) Tax Rate (2014 - 2026) Analysis & Trends

Innoviva has reported Tax Rate for 11 years, with the latest figure at 20.46% in Q1 2026.

  • For the quarter ending Q1 2026, Tax Rate rose 4119.0% year-over-year to 20.46%; the trailing twelve-month figure through Mar 2026 stood at 18.61% (up 4025.0% YoY), and the FY2025 full-year result was 17.03%, down 5420.0% from the prior year.
  • Tax Rate for Q1 2026 stood at 20.46%, up from 8.08% in the prior quarter.
  • The five-year high for Tax Rate was 82.29% in Q3 2024, with the low at 20.73% in Q1 2025.
  • Historically, Tax Rate has averaged 20.1% across 5 years, with a median of 15.25% in 2023.
  • Annual changes were most pronounced in 2023 — Tax Rate soared 8191 bps — and 2025, when it tumbled 7421 bps.
  • Innoviva's Tax Rate stood at 19.93% in 2022, then plunged by 77 bps to 4.54% in 2023, then jumped by 1711 bps to 82.29% in 2024, then plunged by 90 bps to 8.08% in 2025, then surged by 153 bps to 20.46% in 2026.
  • The last three Tax Rate figures came in at 20.46% (Q1 2026), 8.08% (Q3 2025), and 12.27% (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Tax Rate (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn -57.14%
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - 5.61%
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -6.79%
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 17.68%
9 Abivax 90.15 Bn 90.15 Bn - -
10 Innoviva 1.69 Bn 1.08 Bn 75.83 Mn 20.46%

Historic Data

Download Data
DateValue
Mar 31, 2026 20.46%
Mar 31, 2026 20.46%
Sep 30, 2025 8.08%
Sep 30, 2025 8.08%
Jun 30, 2025 12.27%
Jun 30, 2025 12.27%
Mar 31, 2025 -20.73%
Mar 31, 2025 -20.73%
Sep 30, 2024 82.29%
Sep 30, 2024 82.29%
Jun 30, 2024 11.70%
Jun 30, 2024 11.70%
Mar 31, 2024 19.06%
Mar 31, 2024 19.06%
Sep 30, 2023 4.54%
Sep 30, 2023 4.54%
Jun 30, 2023 77.52%
Jun 30, 2023 77.52%
Mar 31, 2023 15.25%
Mar 31, 2023 15.25%